Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 2,145 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Site Clear all

Conditions: Pain, Postoperative, Hysterectomy, Narcotic Use, Cryotherapy Effect
Interventions: Ice packs plus usual post-op analgesia, Usual post-op analgesia; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Actinic Keratoses
Interventions: Diclofenac Sodium Gel, Solaraze 3% Topical Gel, Placebo; Drug · Other
Lead sponsor: Encube Ethicals Pvt. Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 655 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 24
States / cities: Bryant, Arkansas • San Ramon, California • Coral Gables, Florida + 20 more

Conditions: Wound of Skin, Non-melanoma Skin Cancer, Skin Graft Complications, Wound of Lower Leg, Wound of Knee
Interventions: Nanofat-seeded biological scaffold on surgical defect; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: Transitions of Care Coordinator, Usual Care; Other
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Urinary Incontinence, Erectile Dysfunction
Interventions: Intraoperative nerve monitoring; Device
Lead sponsor: ProPep Surgical, LLC; Industry
Eligibility: 40 Years to 70 Years · Male only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Tooth Extraction Status Nos
Interventions: consent, Screening, Xray, PVS Impressions, Photographs, CBCT, Anesthesia, Extraction, Clinical measurements; Other · Procedure
Lead sponsor: Gustavo Avila-Ortiz DDS, MS, PhD; Other
Eligibility: 18 Years to 75 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Post-Traumatic Stress Disorder
Interventions: Interactive Healthcare Communication Application, Control Web sites; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Central Nervous System Infections, Pseudotumor Cerebri, Neurological Disorder, Cancer, Obstetric Procedure Pain, Orthopedic Procedure Pain, Post-Dural Puncture Headache
Interventions: Tactile Imaging (VerTouch), Control (palpation); Device · Other
Lead sponsor: IntuiTap Medical, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 3
States / cities: Providence, Rhode Island • Charleston, South Carolina • Houston, Texas

Conditions: Diabetes Mellitus
Interventions: Raisins, Snacks; Other
Lead sponsor: Louisville Metabolic and Atherosclerosis Research Center; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Chronic Disease
Interventions: Text Messaging; Behavioral
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: IMPLELLA LP 2.5, IABP Intra-aortic balloon pump; Device
Lead sponsor: Abiomed Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 44
States / cities: Birmingham, Alabama • Gilbert, Arizona • Phoenix, Arizona + 35 more

Conditions: Depression, Anxiety, Substance Use Disorder (SUD), Post Traumatic Stress Disorder
Interventions: Microcurrent Neurofeedback (MCN), Standard Care for Substance Use Disorder; Device · Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 18 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: HIV Counseling and Testing, HIV Risk Behavior, HIV Prevention
Interventions: Healthcare counseling service; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: tetomilast, placebo; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 15
States / cities: Birmingham, Alabama • Torrance, California • Kissimmee, Florida + 12 more

Conditions: Gingival Recession
Interventions: Geistlich Fibro-Gide, Connective Tissue Graft (CTG; Device · Procedure
Lead sponsor: Geistlich Pharma AG; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Fenton, Michigan • Houston, Texas • Tacoma, Washington

Conditions: Cross Infection, Pneumonia, Ventilator-associated, Catheter-related Infections, Infection Due to Indwelling Urinary Catheter, Surgical Wound Infection
Interventions: Chlorhexidine gluconate, Standard bathing; Drug · Other
Lead sponsor: Joshua Swan; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type2diabetes, Diabetic Kidney Disease
Interventions: Investigational Product - MIB 626, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 30 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypersensitivity
Interventions: Butenafine HCl 1% (BAY1896425), Positive Control-Sodium lauryl sulfate (SLS), Negative Control; Drug · Other
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Fairfield, New Jersey

Conditions: Cosmetics, Suture, Cicatrix
Interventions: running subcuticular closure of excisional defect; Procedure
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Lung Cancer
Interventions: Engaged Approach to Lung Cancer Screening; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Eosinophilic Asthma
Interventions: Reslizumab, Placebo; Drug
Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 315 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 26
States / cities: Anaheim, California • Fountain Valley, California • Los Angeles, California + 21 more

Conditions: Cerebral Palsy
Interventions: Stochastic Resonance (SR); Device
Lead sponsor: University of Delaware; Other
Eligibility: 8 Years to 8 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Pelvic Organ Prolapse
Interventions: Bupivacaine, Placebo; Drug
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pain
Interventions: Saline Solution for Injection, Exparel; Drug
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 35 Years to 75 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Brooklyn, New York

Search by objective public record fields.

Abdominal Ice Packs for Pain Control and Reduction of Narcotic Use Following Laparoscopic Hysterectomy

Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

Efficacy and Safety of a Nanofat-seeded Biological Scaffold in Healing Lower Limb Surgical Defects

Stroke Transitions of Care to Reduce Hospital Length of Stay

Intraoperative Nerve Monitoring During Robot-assisted Laparoscopic Prostatectomy

Periodontal Phenotype Study (Tooth Extraction)

Effectiveness of a Web-based Intervention for Guardians of Children Whose One Parent Has Murdered the Other

A Study to Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control

Study of Raisins Versus Alternative Snacks in Patients With Type 2 Diabetes Mellitus

Self-Management Using Text Messaging in a Homeless Population

Protect II, A Prospective, Multicenter Randomized Controlled Trial

Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders

Safe Spaces 4 Sexual Health

Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema

Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months

Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit

NAD Augmentation in Diabetes Kidney Disease

Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)

Polyglactin 910 vs Poligelecaprone 25 Running Subcuticular Closure of Elliptical Excision Wounds

Testing the Engaged Approach to Lung Cancer Screening

A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

Neuromotor Control During Walking in Children With Cerebral Palsy

Improvement of Pain Following Robotic Sacrocolpopexy and Rectocele Repair for Pelvic Organ Prolapse

EXPAREL for Minimally Invasive Supracervical Hysterectomies